| Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models MW Ku, M Bourgine, P Authié, J Lopez, K Nemirov, F Moncoq, A Noirat, ... Cell host & microbe 29 (2), 236-249. e6, 2021 | 127 | 2021 |
| Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic mice MW Ku, P Authié, M Bourgine, F Anna, A Noirat, F Moncoq, B Vesin, ... EMBO Molecular Medicine 13 (12), e14459, 2021 | 26 | 2021 |
| A single dose of NILV-based vaccine provides rapid and durable protection against Zika virus MW Ku, F Anna, P Souque, S Petres, M Prot, E Simon-Loriere, ... Molecular Therapy 28 (8), 1772-1782, 2020 | 25 | 2020 |
| Lentiviral vector induces high-quality memory T cells via dendritic cells transduction MW Ku, P Authié, F Nevo, P Souque, M Bourgine, M Romano, ... Communications Biology 4 (1), 713, 2021 | 23 | 2021 |
| Use of lentiviral vectors in vaccination MW Ku, P Charneau, L Majlessi Expert Review of Vaccines 20 (12), 1571-1586, 2021 | 19 | 2021 |
| A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity J Lopez, F Anna, P Authié, A Pawlik, MW Ku, C Blanc, P Souque, ... Cell Reports 40 (4), 2022 | 8 | 2022 |
| Intranasal vaccination with a lentiviral vector strongly protects against SARS-CoV-2 in mouse and golden hamster preclinical models MW Ku, M Bourgine, P Authié, J Lopez, K Nemirov, F Moncoq, A Noirat, ... BioRxiv, 2020.07. 21.214049, 2020 | 6 | 2020 |
| Full brain and lung prophylaxis against SARS-CoV-2 by intranasal lentiviral vaccination in a new hACE2 transgenic mouse model or golden hamsters MW Ku, P Authié, M Bourgine, F Anna, A Noirat, F Moncoq, B Vesin, ... BioRxiv, 2021.02. 03.429211, 2021 | 3 | 2021 |
| Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters B Vesin, P Authié, C Blanc, I Fert, A Noirat, F Le Chevalier, Y Wei, MW Ku, ... Vaccines 11 (1), 12, 2022 | 2 | 2022 |
| A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine … J Brunet, Z Choucha, M Gransagne, H Tabbal, MW Ku, J Buchrieser, ... Journal of Virology, e01693-23, 2024 | 1 | 2024 |
| Brain and lung cross-protection against ancestral or emerging SARS-CoV-2 by intranasal lentiviral vaccination in a New hACE2 transgenic murine model MW Ku, P Authié, M Bourgine, F Anna, A Noirat, F Moncoq, B Vesin, ... | 1 | 2021 |
| DNA origami vaccine (DoriVac) nanoparticles improve both humoral and cellular immune responses to infectious diseases YC Zeng, OJ Young, L Si, MW Ku, G Isinelli, A Rajwar, A Jiang, ... bioRxiv, 2024 | | 2024 |
| Application of lentiviral vector in vaccinology MW Ku Université Paris Cité, 2020 | | 2020 |
| Intranasal Immunization with a Lentiviral Vector Coding for SARS-CoV-2 Spike Protein Confers Vigorous Protection in Pre-Clinical Animal Models (preprint) L MAJLESSI, MW Ku, M Bourgine, P Authie, J Lopez, K Nemirov, ... | | 2020 |
| Intranasal Immunization with a Lentiviral Vector Coding for SARS-CoV-2 Spike Protein Confers Vigorous Protection in Pre-Clinical Animal Models MW Ku, M Bourgine, P Authie, J Lopez, K Nemirov, F Moncoq, A Noirat, ... | | 2020 |
